1Cairncross JG. The biology of astrocytoma: lesson learned from chronic myelogenous leukemia-hypothesis. J Neurooncol, 1987, 5:99-104.
2Uchida N, Buch DW, He D, et al. Direct isolation of human central nervous system stem cells. Proc Natl Acad Sci USA,2000,97:15720-15725.
3Galli R, Binda E, Orfanelli U, et al. Isolation and characterization of tumorigenic, stem-like neural precursors from human glioblastoma. Cancer Res, 2004,64:7011-7021.
4Singh SK, Ian DC, Mizuhiki T, et al. Identification of a cancer stem cell in human brain tumors. Cancer Res,2003, 63:5821-5828.
5Houman DH, Ichiro N, Jorge AL, et al. Cancerous stem cells can arise from pediatric brain tumors. Proc Natl Acad Sci, 2003,100:15178-15183.
6Ignatova TN, Valery GK, Eric DL, et al. Human cortical glial tumors contain neural stem-like cells expressing astroglial and neuronal markers in vitro. Glia, 2002, 39:193-206.
7Kondo T, Setoguchi T, Taga T, et al. Persistence of a small subpopulation of cancer stem-like cells in the C6 glioma cell line. Proc Natl Acad Sci, 2004,101:781-786.
9Singh SK, Hawkins C, Clarke ID, et al. Identification of human brain tumour initiating cells. Nature,2004,432:396-401.
10Clarke MF. At the root of brain cancer. Nature,2004, 432: 281-282.
二级参考文献35
1Fuller GN, Hess KR, Rlaee CH, et al. Molecular classification of human diffuse glimas by multidimensional scaling analysis of gene expression profiles parallels morphology - based classification, correlates with survival, and reveals clinically- relevant novel glioma subsets. Brain Pathol, 2002,12(1): 108- 116.
2Coons SW, Johnson PC, Scheithauer BW, et al. Improving diagnostic accuracy and interobserver concordance in the classlfication and grading of primary gliomas. Cancer, 1997,79(7): 1381 - 1393.
3Uekik,Nishikawa R,Nakazato Y,et al.Correlation of histology and molecular genetic analysis of 1p,19q,10q,TP53,EGFR,CDK4,and CDKN2A in 91 astrocytic and oligodend roglial tumors.Clin Cancer Res,2002,8(1):196-201
4Watanabe K, Tachibana O, Sato K, et al. Overexpression of the EGF receptor and p.53 mutations are mutually exclusive in the evolution of primary and secondary glioblastomas. Brain Pathol, 1996, 6(3) : 217 -223.
5Louis DN, van Deimling A, Chung RY, et al. Comparative study of p53 gene and protein alterations in human astrocytomas.J Neuropathol Exp Neurol,1993,52(1):31-38
6Reifenberger J, Ring GU, Gies U, et al. Analysis of p53 mutation and epidermal growth factor receptor amplification in recurrent gliomas with malignant prgression.J Neuropathol Exp Neurol,1996,55(7):822-831
7Schmidt MC,Antweiler S,Urban N,et al.Impact of genotype and morphology on the prognosis of glioblastoma.J Neuropathol Exp Neurol,2002,61(4):321-328
8lno Y, Zlatescu MC, Sasaki H, et al.Long patient survival and therapeutic responses in histologyically disparate high grade gliomas with chromosome 1p loss.J Neurosurg,2000,92(6):983-990
9lnn Y,Betensky RA,Zlatescu MC,et al.Molecular subtypes of anaplastic oligodendroglioma:implications for patient management and diagnosis.Clin Cancer Res,2001,7(4):839-845
10Caimcross JG,Ueki K,Zlatescu MC,et al.Specific chromosomal losses predict chemotherapeutic response and survival in patients with anaplastic oligodendrogliomas.J Natl Cancer lnst,1998,9(19):1473-1479
